Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
HM2024-11: A PHASE III, MULTICENTER, RANDOMIZED, OPEN;LABEL STUDY COMPARING THEEFFICACY AND SAFETY OF GLOFITAMAB (RO7082859) IN COMBINATION WITH POLATUZUMAB VEDOTINPLUS RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, AND PREDNISONE (POLA-R-CHP) VERSUSPOLATU
Desai, S. (PI)
HOFFMANN-LA ROCHE PHARMACEUTICALS
4/5/24 → 4/30/34
Project: Research project
-
A PHASE II STUDY EVALUATING THE SAFETY AND EFFICACY OF GLOFITAMAB IN COMBINATION WITHRITUXIMAB (R) PLUS CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, AND PREDNISONE CHOP) INCIRCULATING TUMOR (ct)DNA HIGH-RISK PATIENTS WITH UNTREATED DIFFUSE LARGE B-CELL
Desai, S. (PI)
HOFFMANN-LA ROCHE PHARMACEUTICALS
5/17/22 → 3/31/24
Project: Research project
-
Cell of origin is not associated with outcomes of relapsed or refractory diffuse large B cell lymphoma
Desai, S. H., Mwangi, R., Smith, A. N., Maurer, M. J., Farooq, U., King, R. L., Cerhan, J. R., Feldman, A. L., Habermann, T. M., Thompson, C. A., Wang, Y., Ansell, S. M., Witzig, T. E. & Nowakowski, G. S., Feb 2023, In: Hematological Oncology. 41, 1, p. 39-49 11 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Checkpoint inhibitor-based salvage regimens prior to autologous stem cell transplant improve event-free survival in relapsed/refractory classic Hodgkin lymphoma
Desai, S. H., Spinner, M. A., David, K., Bachanova, V., Goyal, G., Kahl, B., Dorritie, K., Azzi, J., Kenkre, V. P., Arai, S., Chang, C., Fusco, B., Sumransub, N., Hatic, H., Saba, R., Ibrahim, U., Harris, E. I., Shah, H., Murphy, J. & Ansell, S. & 10 others, , Mar 2023, In: American Journal of Hematology. 98, 3, p. 464-471 8 p.Research output: Contribution to journal › Article › peer-review
Open Access9 Scopus citations -
Effect of cumulative dose of brentuximab vedotin maintenance in relapsed/refractory classical Hodgkin lymphoma after autologous stem cell transplant: an analysis of real-world outcomes
Wagner, C. B., Boucher, K., Nedved, A., Micallef, I. N., Desai, S., Hatic, H., Goyal, G., Zacholski, E., Fegley, A., Sigmund, A. M., Bond, D. A., Samuels, C., Kamdar, M. K., Aqeel, S. B., Torka, P., MacDougall, K., Borogovac, A., Rajeeve, S., Sundaram, S. & Fedak, K. & 10 others, , Nov 2023, In: Haematologica. 108, 11, p. 3025-3032 8 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era
Desai, S. H., Spinner, M. A., Evens, A. M., Sykorova, A., Bachanova, V., Goyal, G., Kahl, B., Dorritie, K., Azzi, J., Kenkre, V. P., Chang, C., Michalka, J., Ansell, S. M., Fusco, B., Sumransub, N., Hatic, H., Saba, R., Ibrahim, U., Harris, E. I. & Shah, H. & 14 others, , Dec 12 2023, In: Blood Advances. 7, 23, p. 7295-7303 9 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Increasing tissue requirements in lymphoma trials may exclude patients with high-risk disease or worse prognosis
Desai, S. H., Mwangi, R., Ng, W. L., King, R. L., Maurer, M. J., Cerhan, J. R., Feldman, A. L., Farooq, U., Mou, E., Habermann, T. M., Thompson, C. A., Wang, Y., Witzig, T. E. & Nowakowski, G. S., Dec 27 2022, In: Blood Advances. 6, 24, p. 6180-6186 7 p.Research output: Contribution to journal › Article › peer-review
Open Access